Trials / Completed
CompletedNCT02096653
Fluoroscopically-guided Versus Landmark-guided Sacroiliac Joint Injections
Randomized, Controlled, Double-blind, Comparative-effectiveness Study Comparing Fluoroscopically-guided and Landmark-guided Sacroiliac Joint Injections
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 125 (actual)
- Sponsor
- Johns Hopkins University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
In this study, the investigators are attempting to determine whether intra- or extra-articular injections are more effective; the relative prevalence rate of intra-articular and extra-articular SI joint pain; and the accuracy of extra-articular injections using fluoroscopy as the reference standard. 124 consecutive patients with mechanical low back pain below L5, tenderness overlying the SI joint(s) and at least 3 positive provocative maneuvers will be randomized to receive SI joint injections by 2 different approaches. Group 1 will receive fluoroscopically-guided injections into the joint. Group 2 will receive landmark-guided injections into the tender area around the joint. In order to determine whether the injection in group 2 was intra-articular or extra-articular, an x-ray will be done after the injection to ascertain the location of contrast spread. The primary outcome measure will be pain relief at 1-month. Patients who obtain benefit at 1-month will be followed at 3-months, while those who fail to obtain benefit will exit the study to receive alternative care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | X-ray SI joint steroid injection | Injection of steroid and local anesthetic into the joint cavity using fluoroscopic guidance |
| PROCEDURE | Landmark-guided SI steroid injection | Injection of steroid into the joint area based on palpation. The injection may be inside the joint (intra-articular) or outside the joint in the ligaments (extra-articular) |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2017-11-01
- Completion
- 2017-11-01
- First posted
- 2014-03-26
- Last updated
- 2018-02-07
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02096653. Inclusion in this directory is not an endorsement.